Conclusion Of Non-Exclusive Discount Agreements According To §§ 130A Abs. 8/130C Abs. 1 Sgb V For Drugs With The Active Ingredient Fluorouracil (D11Af05) As Part Of A So-Called Open House Model.

AOK Rhineland-Palatinate Saarland - The health insurance company Germany has Released a tender for Conclusion Of Non-Exclusive Discount Agreements According To §§ 130A Abs. 8/130C Abs. 1 Sgb V For Drugs With The Active Ingredient Fluorouracil (D11Af05) As Part Of A So-Called Open House Model. in Pharmaceuticals. The tender was released on Jul 18, 2023.

Country - Germany

Summary - Conclusion Of Non-Exclusive Discount Agreements According To §§ 130A Abs. 8/130C Abs. 1 Sgb V For Drugs With The Active Ingredient Fluorouracil (D11Af05) As Part Of A So-Called Open House Model.

Deadline - Jun 30, 2025

GT reference number - 68993746

Product classification - Pharmaceutical products